Lenacapavir PrEP Drug Review

This is a news story, published by Global News, that relates primarily to Health Canada news.

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Global News news

For more news from Global News, you can click here:

more news from Global News

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Gilead drug

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest new HIV news, Gilead Canada news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Canadian AIDS Treatment Information Exchange

Global News

•

Health

‘Monumental’ HIV shot could be coming to Canada. What we know | Globalnews.ca

Summary

Nutrition label

71% Informative

Gilead Canada submitted lenacapavir for pre-exposure prophylaxis (PrEP) use as a new injectable drug to Health Canada in April of this year .

The drug nearly eliminated new infections in two groundbreaking studies of people at high risk.

The U.S. Food and Drug Administration approved it in that country last week .

Health Canada says it is not responsible for its availability or distribution on the Canadian market.

Some of that I think people are using the cost as, I don’t really want to talk about it,’ but nonetheless it’s a huge barrier to say, I can’t afford this.'” According to the Public Health Agency of Canada , as of 2022 54 per cent of HIV-PrEP prescriptions were paid for by private insurance, while 43 per cent was paid by public coverage. —with files from The Associated Press .

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

possibly offensive

Hate speech

not hateful